Peripheral blood lymphocyte subsets and natural killer cell number and function during alpha-interferon treatment for hairy cell leukemia.
Gibson
J
J
Haematology Department, Royal Prince Alfred Hospital, Camperdown, N.S.W.
Gallagher
K
K
Cameron
K
K
Basten
A
A
Gatenby
P
P
Joshua
D
D
Kronenberg
H
H
D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007694:Killer Cells, Natural; D007943:Leukemia, Hairy Cell / Q000276:immunology / Q000628:therapy*; D007958:Leukocyte Count; D008137:Longitudinal Studies; D008297:Male; D012074:Remission Induction; D013601:T-Lymphocytes / Q000145:classification*
D007370:Interferon Type I